Presentation is loading. Please wait.

Presentation is loading. Please wait.

1 PLIVA, a Member of the Teva Group Tihomir Oreskovic President of the Management Board, Pliva Croatia Ltd. October, 2013 Croatia & SEE.

Similar presentations


Presentation on theme: "1 PLIVA, a Member of the Teva Group Tihomir Oreskovic President of the Management Board, Pliva Croatia Ltd. October, 2013 Croatia & SEE."— Presentation transcript:

1 1 PLIVA, a Member of the Teva Group Tihomir Oreskovic President of the Management Board, Pliva Croatia Ltd. October, 2013 Croatia & SEE

2 2 About TEVA – Strong Foundations Over 46,000 employees 73 manufacturing sites 111 years in existence $20.3B 2012 revenues $ EPS 1,000 molecules 60 countries 70B tablets and capsules per annum 55,000+ SKUs Croatia & SEE

3 3 Core Strenghts 3 Leading healthcare provider Balanced business model Integrated R&D Manufacturing strengths Partnering experience Go-to-market capabilities Entrepreneurial employees and culture Croatia & SEE

4 4 PLIVA in Croatia – Pharma Leader in SEE PLIVA, a member of the Teva Group (since 2008). Established in 1921 The largest pharmaceutical company in Croatia and one of the leading pharma companies in SEE generics inovative products and therapies (Copaxone...) regional partnerships One of major exporters in Croatia >80% for export (30% Russia; 25% USA) 2000 employees in Croatia Croatia & SEE

5 5 Working from Croatia Over 60 locations worldwide EU RUSSIA ASIA JAPAN SAR LATAM USA CANADA Croatia & SEE

6 6 Croatia - Strategically Important Production Site for TEVA New investment cycle in production Teva is investing $200M+ in Croatia (2011 – 2014) Significant expansion of production capacities in Zagreb Construction of a new manufacturing plant and supporting facilities in Savski Marof Vertically integrated production -highly sophisticated products FDA approved - regularly audited by the FDA (since 1965), EMEA and other Higly qualified employees Knowledge and best practice sharing Croatia & SEE

7 7 Operations Croatia $100M+ construction of Sterile and Oral Solid Forms facilities Technology driven manufacturing site Significantly increased production capacities 80% for exports Capacity 10B tabs Complying with the highest global quality standards Markets: US, EMIA, EU; >80% for export (30% Russia; 25% USA) Croatia & SEE

8 8 TAPI Croatia - Worlds Largest AZI Supplier $100M+ the construction of the state-of-the-art facilities Investment in integrated environmental protection ($20M) Supplying 90 % of AZI demand on regulated markets 100 % increase in production capacities Chemical development center (98% for exports) Markets: US, EMIA, EU, JP, CA, LATAM Croatia & SEE

9 9 PLIVAs R&D Center of Excellence 200+ highly skilled employees in R&D Experience and knowledge in development of complex projects Understanding of regulatory requirements: EU, US, CAN, EMIA, ASIA... One of the biggest users of the R&D tax incentives in Croatia R&D Croatia - holder of Teva's strategy for the development of complex products and NTEs Croatia & SEE

10 10 Beyond Production and R&D Finance SSC SSC Zagreb Providing services to different sites/countries in EU, EMIA, Asia, Americas IT SSC Pharmakovigilance Business development Regulatory HR Legal Communications Procuirment Quality Regional & Global support Croatia & SEE

11 11 Working with Croatian Companies – Capabilities, Potentials and Opportunities Croatia located in the heart of Central Europe the leading market for SEE region, highly skilled and educated people average salaries below the EU average EU member July 2013 Competitive incentives, R&D, employment capital Croatia & SEE

12 12 Thank you!


Download ppt "1 PLIVA, a Member of the Teva Group Tihomir Oreskovic President of the Management Board, Pliva Croatia Ltd. October, 2013 Croatia & SEE."

Similar presentations


Ads by Google